Study Stopped
Principal Investigator elected to end the study.
Effect of Turner Syndrome on Number Sense
Investigation of the Role of Turner Syndrome on Approximate Number Sense
1 other identifier
interventional
N/A
1 country
1
Brief Summary
This study evaluates approximate number sense (ANS) in children, adolescents, and adult women with Turner syndrome compared to age-matched healthy peers. One primary aim of this project is to assess the effectiveness of an online ANS training tool in enhancing complex mathematics ability. Participants will undergo weekly training sessions in their own home. Half of the participants will complete 2 training sessions a week for 8 weeks, and the second half will complete 1 training session for 8 weeks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Apr 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 27, 2018
CompletedFirst Posted
Study publicly available on registry
March 9, 2018
CompletedStudy Start
First participant enrolled
April 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 2, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 2, 2022
CompletedMay 9, 2022
May 1, 2022
1 day
February 27, 2018
May 3, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Single and multiple-operand addition and subtraction accuracy
Task accuracy calculated as the percentage of trials answered correctly.
8 weeks
Single and multiple-operand addition and subtraction response time
Average amount of time, in seconds, required to answer each question on the task.
8 weeks
Study Arms (1)
ANS training
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- Children, adolescents, and adult women with Turner syndrome.
- Healthy controls.
- Normal or corrected to normal vision.
You may not qualify if:
- Major psychiatric or developmental disorder (e.g., bipolar disorder, major depression, psychotic disorders, intellectual disability, autism spectrum disorder).
- Chemical dependency
- Currently taking the following medications: antidepressant, antipsychotic, and anti-seizures drugs.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Center for Interdisciplinary Brain Sciences Research
Stanford, California, 94305, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Instructor
Study Record Dates
First Submitted
February 27, 2018
First Posted
March 9, 2018
Study Start
April 1, 2022
Primary Completion
April 2, 2022
Study Completion
April 2, 2022
Last Updated
May 9, 2022
Record last verified: 2022-05